| A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer (NCT05415215) | Hoffmann-La Roche | 2022-07-05 |
| Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status (NCT05217381) | MedSIR | 2022-02-22 |
| A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) (NCT04961996) | Hoffmann-La Roche | 2021-08-27 |
| Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer (NCT04733118) | MedSIR | 2021-08-05 |
| Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer (NCT04659499) | Peking Union Medical College Hospital | 2021-01-01 |
| Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients (NCT04293393) | Spanish Breast Cancer Research Group | 2020-10-02 |
| GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel (NCT04538833) | Henan Cancer Hospital | 2020-09-09 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer) (NCT04436744) | Hoffmann-La Roche | 2020-09-04 |
| The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer (NCT04291378) | Danish Breast Cancer Cooperative Group | 2020-06-01 |
| Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients (NCT05730647) | Consorzio Oncotech | 2019-10-24 |
| Activity Program During Aromatase Inhibitor Therapy (NCT03786198) | Swiss Cancer Institute | 2019-03-28 |
| A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer (NCT03701334) | Novartis Pharmaceuticals | 2018-12-07 |
| Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (NCT03499353) | Pfizer | 2018-08-27 |
| A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer (NCT03493854) | Hoffmann-La Roche | 2018-06-14 |
| Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer (NCT03520894) | Azienda Ospedaliero-Universitaria Careggi | 2018-05-01 |
| Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD) (NCT03949634) | Fudan University | 2017-09-01 |
| Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer (NCT07404462) | Institute of Oncology Ljubljana | 2017-03-01 |
| A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC) (NCT02738970) | Hoffmann-La Roche | 2016-06-23 |
| Innovative "Scoring System" in Breast Cancer Post Neoadiuvant Chemotherapy (NCT05213403) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2016-01-01 |
| Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection (NCT04137744) | Zagazig University | 2015-02-01 |
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (NCT02308085) | ETOP IBCSG Partners Foundation | 2014-12-04 |
| A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04) (NCT02187744) | Pfizer | 2014-09-23 |
| A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1) (NCT01919229) | Novartis Pharmaceuticals | 2013-10-01 |
| A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. (NCT01792726) | University College, London | 2013-06-01 |
| Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients (NCT01155063) | Pfizer | 2010-09-01 |
| Feasibility of Ambulatory Surgery for Early Breast Cancer (NCT01613352) | Helsinki University Central Hospital | 2008-03-01 |
| Arthralgia During Anastrozole Therapy for Breast Cancer (NCT00323479) | AstraZeneca | 2006-06-01 |
| Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer (NCT00713141) | National University Hospital, Singapore | 2004-11-01 |
| Electronic Study for Anastrozole Pharmacovigilance Evaluation (NCT00558168) | AstraZeneca | 2004-01-01 |